DME Treatment Fundamentals IME Platform: Improving Visual Outcomes in DME Patients with Current and Emerging Treatments
2 September, 09.45 – 10.45 CEST
Hall 3
Chairperson(s):
R. Schlingemann NETHERLANDS
Recent Advances in Multimodal Imaging and Artificial intelligence in Ophthalmology
2 September, 09.45 – 10.45 CEST
Hall G1
Chairperson(s):
S. Srinivas USA
Smaller, Faster, Closer – Precision in Retina Surgeries
2 September, 09.45 – 10.45 CEST
Hall G2
Chairperson(s):
F. Patelli ITALY
UWF Multimodal Imaging and Microperimetry – Enhancing the Bridge between Structure and Function
2 September, 09.45 – 10.45 CEST
Hall X1
Chairperson(s):
R. Abreu Gonzalez SPAIN
Heidelberg AppWay: Secure workflow solution for access to ophthalmic applications and AI algorithms
2 September, 13.45 – 14.45 CEST
Hall E
Chairperson(s): C. Mody UK
Advancing the management of nAMD: Latest clinical insights from targeting Ang-2/VEGF-A via dual inhibition
2 September, 13.45 – 14.45 CEST
Hall 3
Chairperson(s):
F. Holz GERMANY
How LASER has changed since coronavirus struck ?
2 September, 13.45 – 14.45 CEST
Hall X1
Chairperson(s):
V. Chong UK
Reducing the burden of DME – what matters in clinical management?
2 September, 13.45 – 14.45 CEST
Hall G1
Chairperson(s):
A. Loewenstein ISRAEL
Benefits beyond vision: 10 years of delivering outcomes that matter
2 September, 13.45 – 14.45 CEST
Hall 4
Chairperson(s):
A. Stahl GERMANY
Evolving Management in Diabetic Macula Edema
2 September, 13.45 – 14.45 CEST
Hall G2
Chairperson(s):
D. Zur ISRAEL,
M. Iglicki ARGENTINA
OCTA-A Innovations: deeper, wider, and beyond Ophthalmology TBC
2 September, 13.45 – 14.45 CEST
Hall X2
Chairperson(s): M. Munk SWITERLAND
Expert clinical insights: How continuous delivery of anti-VEGF is changing the management of nAMD
2 September, 17.45 – 18.45 CEST
Hall X2
Chairperson(s):
A. Wolf GERMANY
EVA NEXUS™: The Future of Ophthalmic Surgery
2 September, 18.15 – 19.15 CEST
Hall G1
Chairperson(s):
G. Pertile ITALY